查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1400999

肥大細胞腫瘤治療市場，按藥物類別、給藥途徑、配銷通路、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Mast Cell Tumors Treatment Market, By Drug Class, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 79 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年，肥大細胞腫瘤治療市場規模達 51 億美元，2023 年至 2030 年CAGR為 3.6%。

肥大細胞腫瘤治療市場-市場動態

獸醫腫瘤學日益重視精準醫療推動市場需求

隨著對 MCT 發生和進展的遺傳和分子機制了解的加深，標靶治療變得越來越可能。這種個人化方法根據腫瘤的個別特徵客製化藥物，最大限度地提高療效，同時最大限度地減少負面影響。在個體腫瘤的遺傳和分子分析的引領下，創新標靶藥物和免疫療法的開發正在獲得關注。這種促進因素​​不僅可以改善治療效果，還可以改善患有 MCT 和其他惡性腫瘤的狗的整體生活品質。

肥大細胞腫瘤治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，全球肥大細胞腫瘤治療市場預計在預測期（2023-2030）每年將以 3.6% 左右的CAGR成長

由於獸醫腫瘤學中對精準醫療的日益重視，肥大細胞腫瘤治療產業預計將以顯著的速度成長。

根據藥物類別細分，預計腎上腺素將在 2022 年顯示最大的市場佔有率

根據給藥途徑細分，注射劑是 2022 年領先的藥物類別

按地區分類，亞太地區是 2022 年領先的收入來源

肥大細胞腫瘤治療市場-細分分析：

全球肥大細胞腫瘤治療市場根據藥物類別、給藥途徑、配銷通路和地區進行細分。

依藥物類別，市場分為四類：抗組織胺、腎上腺素、類固醇、肥大細胞穩定劑。腎上腺素在市場上佔據主導地位。由於 MCT 能夠產生組織胺，在某些情況下可能會引起嚴重的過敏反應，因此治療期間可能需要腎上腺素。作為一種緊急藥物，腎上腺素有助於控制 MCT 脫顆粒引起的過敏反應，從而實現更快的干涉和更好的患者治療效果。

依給藥途徑，市場分為三類：口服、注射、外用。注射劑產業在市場中佔據主導地位，並可能在預測期內保持其主導地位。由於多種原因，注射藥物對於治療肥大細胞腫瘤的需求量很大。它們用於在 MCT 脫粒引起的嚴重過敏反應的情況下提供化療、標靶治療和緊急藥物（例如腎上腺素），從而為這種困難類型的癌症提供成功和快速的治療。

肥大細胞腫瘤治療市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。狗的肥大細胞腫瘤（MCT）在亞太地區越來越流行。這種傾向受到多種因素的影響。該地區多個國家寵物擁有率的提高導致獸醫服務和治療市場蓬勃發展。其次，人們對犬類健康問題，尤其是 MCT 等癌症的了解不斷增加，促使更多的寵物主人為他們的寵物尋求醫療照護。最後，亞太地區獸醫腫瘤學的進步以及越來越多的專業獸醫診所和醫院增加了診斷和治療選擇的機會，滿足了該地區對有效 MCT 治療日益成長的需求。

肥大細胞腫瘤治療市場-競爭格局：

肥大細胞腫瘤 (MCT) 的治療前景是動態的，有多種因素在起作用。化療和標靶藥物可從 Zoetis、Elanco 和 Merck Animal Health 等領先獸醫製藥公司獲得。此外，專門的獸醫癌症中心（例如 PetCure cancer）可以提供複雜的放射治療。旨在開發新藥的研究和開發措施可能會對環境產生影響。製藥公司、研究機構和獸醫診所之間的合作促進了 MCT 療法的進步。隨著人們對寵物醫療保健的日益關注，競爭促進了治療方法的改進，最終幫助犬類 MCT 患者及其家人。

最近的發展：

2023 年5 月，用於非手術皮膚癌和蟹足腫治療的先進醫療設備的領先供應商Sensus Healthcare Inc. 很高興地宣布，他們的淺表放射治療SRT-100 系統在治療皮膚肥大細胞腫瘤方面顯示出令人鼓舞的結果（MCT）在貓咪身上。這項新的限制性研究最近發表在《美國獸醫協會雜誌》上，顯示了 SRT 療法的潛在功效和安全性。

目錄

第1章：肥大細胞腫瘤治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按藥物類別分類的肥大細胞腫瘤治療市場片段
    • 依給藥途徑分類的肥大細胞腫瘤治療市場片段
    • 按配銷通路的肥大細胞腫瘤治療市場片段
    • 按國家/地區分類的肥大細胞腫瘤治療市場片段
    • 按地區分類的肥大細胞腫瘤治療市場片段
  • 競爭洞察

第 3 章：肥大細胞腫瘤治療主要市場趨勢

  • 肥大細胞腫瘤治療市場促進因素
    • 市場促進因素的影響分析
  • 肥大細胞腫瘤治療市場限制
    • 市場限制影響分析
  • 肥大細胞腫瘤治療市場機會
  • 肥大細胞腫瘤治療市場未來趨勢

第 4 章：肥大細胞腫瘤治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：肥大細胞腫瘤治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：肥大細胞腫瘤治療市場格局

  • 2022 年肥大細胞腫瘤治療市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：肥大細胞腫瘤治療市場 - 依藥物類別

  • 概述
    • 按藥物類別分類的細分市場佔有率分析
    • 抗組織胺藥
    • 腎上腺素
    • 類固醇
    • 肥大細胞穩定劑

第 8 章：肥大細胞腫瘤治療市場 - 依給藥途徑

  • 概述
    • 按給藥途徑分類的細分市佔率分析
    • 口服
    • 注射劑
    • 專題

第 9 章：肥大細胞腫瘤治療市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 藥局
    • 網路藥局

第 10 章：肥大細胞腫瘤治療市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 肥大細胞腫瘤治療北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按藥物類別）
    • 北美市場規模與預測（按管理途徑）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 肥大細胞腫瘤治療歐洲主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按藥物類別）
    • 歐洲市場規模與預測（按管理途徑）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 肥大細胞腫瘤治療亞太地區主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模和預測（按藥物類別）
    • 亞太地區市場規模與預測（依管理途徑）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲肥大細胞腫瘤治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按藥物類別）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 肥大細胞腫瘤治療中東和非洲主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按藥物類別）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 肥大細胞腫瘤治療產業

  • 競爭儀表板
  • 公司簡介
    • Zoetis
    • Elanco Animal Health
    • Merck Animal Health
    • Boehringer Ingelheim
    • PetCure Oncology
    • Varian Medical Systems
    • VetDC, Inc.
    • Oasmia Pharmaceutical AB
    • Aratana Therapeutics
    • Rhizen Pharmaceuticals
    • Animal Medical Center
    • Blue Buffalo Foundation
    • Ethos Veterinary Health
    • PetCure Oncology
    • Veterinary Cancer Group

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1963

REPORT HIGHLIGHT

Mast Cell Tumors Treatment Market size was valued at USD 5,100 Million in 2022, expanding at a CAGR of 3.6% from 2023 to 2030.

Mast cell tumors (MCTs) are a kind of cancer that is frequent in dogs. Mast cells, a kind of immune cell implicated in allergic responses and inflammation, are the source of these tumors. MCTs come in a variety of sizes, shapes, and malignancies. Mast cell tumors are normally treated surgically, with the goal of entirely excising the tumor. Additional treatments, such as radiation, chemotherapy, or targeted drugs, may be required in certain circumstances, particularly for aggressive or metastatic tumors. Regular veterinarian check-ups and monitoring are essential for dogs at risk of MCTs since early discovery and timely treatment are critical for a favorable outcome.

Mast Cell Tumors Treatment Market- Market Dynamics

Increasing emphasis on precision medicine in veterinary oncology propel market demand

Targeted therapy becomes increasingly possible as knowledge of the genetic and molecular mechanisms that contribute to MCT genesis and progression improves. This personalized method tailor's medicines to the tumor's individual features, maximizing effectiveness while minimizing negative effects. The development of innovative targeted medications and immunotherapies is gaining traction, led by genetic and molecular analysis of individual tumours. This driver improves not just treatment results but also the entire quality of life for dogs suffering from MCTs and other malignancies.

Mast Cell Tumors Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global Mast Cell Tumors Treatment market is estimated to grow annually at a CAGR of around 3.6% over the forecast period (2023-2030)

The Mast Cell Tumors Treatment industry is projected to grow at a significant rate due to increasing emphasis on precision medicine in veterinary oncology.

Based on Drug Class segmentation, Epinephrine was predicted to show maximum market share in the year 2022

Based on Route of Administration segmentation, Injectables was the leading Drug Class in 2022

On the basis of region, Asia Pacific was the leading revenue generator in 2022

Mast Cell Tumors Treatment Market- Segmentation Analysis:

The Global Mast Cell Tumors Treatment Market is segmented on the basis of Drug Class, Route of Administration, Distribution Channel, and Region.

The market is divided into four categories based on Drug Class: Antihistamines, Epinephrine, Steroids, Mast-cell stabilizers. The Epinephrine dominates the market. Because MCTs have the ability to produce histamines, which may cause severe allergic responses in certain circumstances, epinephrine need may occur during therapy. As an emergency medication, epinephrine aids in the management of anaphylactic responses caused by MCT degranulation, allowing for faster intervention and better patient outcomes.

The market is divided into three categories based on Route of Administration: Oral, Injectables, Topical. The Injectables sector dominates the market and is likely to maintain its dominance during the forecast period. Injectable medicines are in high demand for the treatment of mast cell tumors for a variety of reasons. They are used to deliver chemotherapy, targeted treatments, and emergency medications like as epinephrine in situations of severe allergic responses induced by MCT degranulation, providing successful and speedy treatment of this difficult type of cancer.

Mast Cell Tumors Treatment Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Mast cell tumors (MCTs) in dogs are becoming more popular in the Asia-Pacific area. This tendency is influenced by a variety of things. Increased pet ownership rates in several nations around the area have resulted in a burgeoning market for veterinarian services and treatments. Second, increased knowledge of canine health issues, particularly cancers such as MCTs, has prompted more pet owners to seek medical attention for their pets. Finally, advances in veterinary oncology and an increasing number of specialized veterinary clinics and hospitals in the Asia-Pacific area have enhanced access to diagnostic and treatment choices, satisfying the region's growing need for effective MCT treatments.

Mast Cell Tumors Treatment Market- Competitive Landscape:

The therapy landscape for mast cell tumors (MCTs) is dynamic, with various elements at work. Chemotherapy and targeted medicines are available from leading veterinary pharmaceutical firms such as Zoetis, Elanco, and Merck Animal Health. Furthermore, sophisticated radiation therapy are available at specialized veterinary cancer centers such as PetCure cancer. Research and development initiatives targeted at developing novel medicines can have an impact on the environment. Collaboration among pharmaceutical firms, research institutions, and veterinary clinics promotes MCT therapy advancement. With a rising focus on pet healthcare, competition promotes therapeutic improvements, eventually helping canine MCT sufferers and their families.

Recent Developments:

In May 2023, Sensus Healthcare Inc., a leading provider of sophisticated medical devices for non-surgical skin cancer and keloid scar treatment, is pleased to announce that their superficial radiation therapy SRT-100 system has shown encouraging results in treating Cutaneous Mast Cell Tumours (MCTs) in cats. This new restricted research, which recently appeared in the Journal of the American Veterinary Medical Association, shows the potential efficacy and safety of SRT therapy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MAST CELL TUMORS TREATMENT MARKET KEY PLAYERS

  • Zoetis
  • Elanco Animal Health
  • Merck Animal Health
  • Boehringer Ingelheim
  • PetCure Oncology
  • Varian Medical Systems
  • VetDC, Inc.
  • Oasmia Pharmaceutical AB
  • Aratana Therapeutics
  • Rhizen Pharmaceuticals
  • Animal Medical Center
  • Blue Buffalo Foundation
  • Ethos Veterinary Health
  • PetCure Oncology
  • Veterinary Cancer Group

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY DRUG CLASS

  • Antihistamines
  • Epinephrine
  • Steroids
  • Mast-cell stabilizers

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Injectables
  • Topical

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

GLOBAL MAST CELL TUMORS TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mast Cell Tumors Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mast Cell Tumors Treatment Market Snippet by Drug Class
    • 2.1.2. Mast Cell Tumors Treatment Market Snippet by Route of Administration
    • 2.1.3. Mast Cell Tumors Treatment Market Snippet by Distribution Channel
    • 2.1.4. Mast Cell Tumors Treatment Market Snippet by Country
    • 2.1.5. Mast Cell Tumors Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Mast Cell Tumors Treatment Key Market Trends

  • 3.1. Mast Cell Tumors Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mast Cell Tumors Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mast Cell Tumors Treatment Market Opportunities
  • 3.4. Mast Cell Tumors Treatment Market Future Trends

4. Mast Cell Tumors Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mast Cell Tumors Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Mast Cell Tumors Treatment Market Landscape

  • 6.1. Mast Cell Tumors Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mast Cell Tumors Treatment Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022 & 2030 (%)
    • 7.1.2. Antihistamines
    • 7.1.3. Epinephrine
    • 7.1.4. Steroids
    • 7.1.5. Mast-cell stabilizers

8. Mast Cell Tumors Treatment Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectables
    • 8.1.4. Topical

9. Mast Cell Tumors Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Drug Stores
    • 9.1.5. Online Pharmacies

10. Mast Cell Tumors Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Mast Cell Tumors Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Mast Cell Tumors Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Mast Cell Tumors Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Mast Cell Tumors Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Mast Cell Tumors Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Mast Cell Tumors Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Zoetis
    • 11.2.2. Elanco Animal Health
    • 11.2.3. Merck Animal Health
    • 11.2.4. Boehringer Ingelheim
    • 11.2.5. PetCure Oncology
    • 11.2.6. Varian Medical Systems
    • 11.2.7. VetDC, Inc.
    • 11.2.8. Oasmia Pharmaceutical AB
    • 11.2.9. Aratana Therapeutics
    • 11.2.10. Rhizen Pharmaceuticals
    • 11.2.11. Animal Medical Center
    • 11.2.12. Blue Buffalo Foundation
    • 11.2.13. Ethos Veterinary Health
    • 11.2.14. PetCure Oncology
    • 11.2.15. Veterinary Cancer Group

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Route of Administrations
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Mast Cell Tumors Treatment Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Mast Cell Tumors Treatment Market, by Drug Class 2018-2030 (USD Million)
  • TABLE Mast Cell Tumors Treatment Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Mast Cell Tumors Treatment Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Mast Cell Tumors Treatment Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Mast Cell Tumors Treatment Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Mast Cell Tumors Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Mast Cell Tumors Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Mast Cell Tumors Treatment Market, by Distribution Channel, 2018-2030 (USD Million)